
DRL unveils anti-cancer drug in U.S.
The Hindu
Dr. Reddy’s Laboratories has unveiled Capecitabine Tablets, USP in the U.S market. The drug is a therapeutic equivalent generic version of Xeloda (capecitabine) Tablets, used in the treatment of certain types of cancers.
Xeloda is a trademark of Hoffmann-La Roche Inc. The drug is indicated to treat colon, colorectal and breast cancers.
More Related News

The U.S. has launched two investigations under Section 301 of the Trade Act of 1974 against India and other economies to examine practices that may be ‘unreasonable or discriminatory and burden or restrict U.S. commerce’. One probe examines whether countries, including India, are using excess manufacturing capacity to export to the U.S. in a manner that hurts American businesses, while another looks at whether countries have taken ‘sufficient steps’ to prohibit imports of goods produced with forced labour.












